Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
Candex
United States
- New York, NY
- 30/11/2023
- Series B
- $45,000,000
Candex is a fintech consolidator for large organizations so that they can make purchases from one-time, irregular and low risk suppliers using existing P2P processes. Candex operates globally managing setup, support, tax and regulatory complexity - making it simple, fast, and compliant to pay suppliers even across borders and cross currencies. Available in multiple deliveries, Candex works directly within existing e-procurement systems, via bulk uploads, or integrated into any workflow via API. In the end - Candex completely takes care of the 70-80% of vendors getting 3-5% of spend; ensures that "No PO, No Pay" becomes achievable; and the efficiency is so remarkable that our clients enter a sort of procurement zen.
- Industry Software Development
- Website https://www.candex.com/
- LinkedIn https://www.linkedin.com/company/candex-technologies/about/
Related People
Jeremy LappinFounder
United States -
Miami, Florida
My background is diverse and broad. Over the course of my career, I have personally started or been seriously involved with the formation of five significant companies; I have worked as an analyst at the top financial houses on Wall Street; I have worked for the CEO of one of the largest medical device companies in the world; and I even built a solar powered car capable of sustaining 40 mph on the power of the sun because I thought it would be fun.
I am an active angel investor when I find capable individuals with big ideas in industries that I understand, and I am always looking for a new adventure.
Specialties: Recruitment, web technologies, business services, sales, fund raising, software development, mergers & acquisitions, and finance.
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)